Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Open ventral hernia repair with a composite ventral patch - final results of a multicenter prospective study.

Berrevoet F, Doerhoff C, Muysoms F, Hopson S, Muzi MG, Nienhuijs S, Kullman E, Tollens T, Schwartz M, Leblanc K, Velanovich V, Jørgensen LN.

BMC Surg. 2019 Jul 16;19(1):93. doi: 10.1186/s12893-019-0555-z.

2.

Positron Emission Tomography Imaging of [11 C]Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of Cyclosporin A.

Billington S, Shoner S, Lee S, Clark-Snustad K, Pennington M, Lewis D, Muzi M, Rene S, Lee J, Nguyen TB, Kumar V, Ishida K, Chen L, Chu X, Lai Y, Salphati L, Hop CECA, Xiao G, Liao M, Unadkat JD.

Clin Pharmacol Ther. 2019 Nov;106(5):1056-1066. doi: 10.1002/cpt.1506. Epub 2019 Jul 22.

PMID:
31102467
3.

Evaluating Multisite rCBV Consistency from DSC-MRI Imaging Protocols and Postprocessing Software Across the NCI Quantitative Imaging Network Sites Using a Digital Reference Object (DRO).

Bell LC, Semmineh N, An H, Eldeniz C, Wahl R, Schmainda KM, Prah MA, Erickson BJ, Korfiatis P, Wu C, Sorace AG, Yankeelov TE, Rutledge N, Chenevert TL, Malyarenko D, Liu Y, Brenner A, Hu LS, Zhou Y, Boxerman JL, Yen YF, Kalpathy-Cramer J, Beers AL, Muzi M, Madhuranthakam AJ, Pinho M, Johnson B, Quarles CC.

Tomography. 2019 Mar;5(1):110-117. doi: 10.18383/j.tom.2018.00041.

4.

The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge, Part II.

Huang W, Chen Y, Fedorov A, Li X, Jajamovich GH, Malyarenko DI, Aryal MP, LaViolette PS, Oborski MJ, O'Sullivan F, Abramson RG, Jafari-Khouzani K, Afzal A, Tudorica A, Moloney B, Gupta SN, Besa C, Kalpathy-Cramer J, Mountz JM, Laymon CM, Muzi M, Kinahan PE, Schmainda K, Cao Y, Chenevert TL, Taouli B, Yankeelov TE, Fennessy F, Li X.

Tomography. 2019 Mar;5(1):99-109. doi: 10.18383/j.tom.2018.00027.

5.

Test-Retest Reproducibility of 18F-FDG PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local Network.

Kurland BF, Peterson LM, Shields AT, Lee JH, Byrd DW, Novakova-Jiresova A, Muzi M, Specht JM, Mankoff DA, Linden HM, Kinahan PE.

J Nucl Med. 2019 May;60(5):608-614. doi: 10.2967/jnumed.118.209544. Epub 2018 Oct 25.

PMID:
30361381
6.

Corrigendum: "I Want It All, and I Want It Now": Lifetime Prevalence and Reasons for Using and Abstaining from Controlled Performance and Appearance Enhancing Substances (PAES) among Young Exercisers and Amateur Athletes in Five European Countries.

Lazuras L, Barkoukis V, Loukovitis A, Brand R, Hudson A, Mallia L, Michaelides M, Muzi M, Petróczi A, Zelli A.

Front Psychol. 2018 Jul 25;9:1162. doi: 10.3389/fpsyg.2018.01162. eCollection 2018.

7.

ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy.

Ratai EM, Zhang Z, Fink J, Muzi M, Hanna L, Greco E, Richards T, Kim D, Andronesi OC, Mintz A, Kostakoglu L, Prah M, Ellingson B, Schmainda K, Sorensen G, Barboriak D, Mankoff D, Gerstner ER; ACRIN 6684 trial group.

PLoS One. 2018 Jun 14;13(6):e0198548. doi: 10.1371/journal.pone.0198548. eCollection 2018.

8.

Numerical analysis of electromagnetic interactions by a cell during the mitosis phases.

Mangini F, Muzi M, Frezza F.

Int J Numer Method Biomed Eng. 2018 Sep;34(9):e3110. doi: 10.1002/cnm.3110. Epub 2018 Jun 26.

PMID:
29855163
9.

Multisite Concordance of DSC-MRI Analysis for Brain Tumors: Results of a National Cancer Institute Quantitative Imaging Network Collaborative Project.

Schmainda KM, Prah MA, Rand SD, Liu Y, Logan B, Muzi M, Rane SD, Da X, Yen YF, Kalpathy-Cramer J, Chenevert TL, Hoff B, Ross B, Cao Y, Aryal MP, Erickson B, Korfiatis P, Dondlinger T, Bell L, Hu L, Kinahan PE, Quarles CC.

AJNR Am J Neuroradiol. 2018 Jun;39(6):1008-1016. doi: 10.3174/ajnr.A5675. Epub 2018 May 24.

10.

Prospective Study of Serial 18F-FDG PET and 18F-Fluoride PET to Predict Time to Skeletal-Related Events, Time to Progression, and Survival in Patients with Bone-Dominant Metastatic Breast Cancer.

Peterson LM, O'Sullivan J, Wu QV, Novakova-Jiresova A, Jenkins I, Lee JH, Shields A, Montgomery S, Linden HM, Gralow J, Gadi VK, Muzi M, Kinahan P, Mankoff D, Specht JM.

J Nucl Med. 2018 Dec;59(12):1823-1830. doi: 10.2967/jnumed.118.211102. Epub 2018 May 10.

11.

Inter-operator variability in compartmental kinetic analysis of 18F-fluoromisonidazole dynamic PET.

Nehmeh SA, Schwartz J, Grkovski M, Yeung I, Laymon CM, Muzi M, Humm JL.

Clin Imaging. 2018 May - Jun;49:121-127. doi: 10.1016/j.clinimag.2017.12.015. Epub 2018 Jan 12.

12.

Polarization-maintaining reflection-mode THz time-domain spectroscopy of a polyimide based ultra-thin narrow-band metamaterial absorber.

Astorino MD, Fastampa R, Frezza F, Maiolo L, Marrani M, Missori M, Muzi M, Tedeschi N, Veroli A.

Sci Rep. 2018 Jan 31;8(1):1985. doi: 10.1038/s41598-018-20429-7.

13.

Assessment of a statistical AIF extraction method for dynamic PET studies with 15O water and 18F fluorodeoxyglucose in locally advanced breast cancer patients.

O'Sullivan F, O'Sullivan JN, Huang J, Doot R, Muzi M, Schubert E, Peterson L, Dunnwald LK, Mankoff DM.

J Med Imaging (Bellingham). 2018 Jan;5(1):011010. doi: 10.1117/1.JMI.5.1.011010. Epub 2017 Nov 23.

14.

Toward uniform implementation of parametric map Digital Imaging and Communication in Medicine standard in multisite quantitative diffusion imaging studies.

Malyarenko D, Fedorov A, Bell L, Prah M, Hectors S, Arlinghaus L, Muzi M, Solaiyappan M, Jacobs M, Fung M, Shukla-Dave A, McManus K, Boss M, Taouli B, Yankeelov TE, Quarles CC, Schmainda K, Chenevert TL, Newitt DC.

J Med Imaging (Bellingham). 2018 Jan;5(1):011006. doi: 10.1117/1.JMI.5.1.011006. Epub 2017 Oct 30.

15.

Multisite concordance of apparent diffusion coefficient measurements across the NCI Quantitative Imaging Network.

Newitt DC, Malyarenko D, Chenevert TL, Quarles CC, Bell L, Fedorov A, Fennessy F, Jacobs MA, Solaiyappan M, Hectors S, Taouli B, Muzi M, Kinahan PE, Schmainda KM, Prah MA, Taber EN, Kroenke C, Huang W, Arlinghaus LR, Yankeelov TE, Cao Y, Aryal M, Yen YF, Kalpathy-Cramer J, Shukla-Dave A, Fung M, Liang J, Boss M, Hylton N.

J Med Imaging (Bellingham). 2018 Jan;5(1):011003. doi: 10.1117/1.JMI.5.1.011003. Epub 2017 Oct 10.

16.

Muzi's Tension Free Primary Closure of Pilonidal Sinus Disease: Updates on Long-Term Results on 514 Patients.

Muzi MG, Mascagni P, Buonomo O, Cianfarani A, Mosconi C, Colella M, Balla A, Petrella G, Quaresima S, Sileri P.

J Gastrointest Surg. 2018 Jan;22(1):133-137. doi: 10.1007/s11605-017-3502-2. Epub 2017 Jul 27.

PMID:
28752401
17.

"I Want It All, and I Want It Now": Lifetime Prevalence and Reasons for Using and Abstaining from Controlled Performance and Appearance Enhancing Substances (PAES) among Young Exercisers and Amateur Athletes in Five European Countries.

Lazuras L, Barkoukis V, Loukovitis A, Brand R, Hudson A, Mallia L, Michaelides M, Muzi M, Petróczi A, Zelli A.

Front Psychol. 2017 May 22;8:717. doi: 10.3389/fpsyg.2017.00717. eCollection 2017. Erratum in: Front Psychol. 2018 Jul 25;9:1162.

18.

Practice Model for Advanced Practice Providers in Oncology.

Cairo J, Muzi MA, Ficke D, Ford-Pierce S, Goetzke K, Stumvoll D, Williams L, Sanchez FA.

Am Soc Clin Oncol Educ Book. 2017;37:40-43. doi: 10.14694/EDBK_175577.

PMID:
28561709
19.

A multicenter prospective study of patients undergoing open ventral hernia repair with intraperitoneal positioning using the monofilament polyester composite ventral patch: interim results of the PANACEA study.

Berrevoet F, Doerhoff C, Muysoms F, Hopson S, Muzi MG, Nienhuijs S, Kullman E, Tollens T, Schwartz MR, LeBlanc K, Velanovich V, Jørgensen LN.

Med Devices (Auckl). 2017 May 12;10:81-88. doi: 10.2147/MDER.S132755. eCollection 2017.

20.

Multi-site quality and variability analysis of 3D FDG PET segmentations based on phantom and clinical image data.

Beichel RR, Smith BJ, Bauer C, Ulrich EJ, Ahmadvand P, Budzevich MM, Gillies RJ, Goldgof D, Grkovski M, Hamarneh G, Huang Q, Kinahan PE, Laymon CM, Mountz JM, Muzi JP, Muzi M, Nehmeh S, Oborski MJ, Tan Y, Zhao B, Sunderland JJ, Buatti JM.

Med Phys. 2017 Feb;44(2):479-496. doi: 10.1002/mp.12041.

21.

A virtual clinical trial comparing static versus dynamic PET imaging in measuring response to breast cancer therapy.

Wangerin KA, Muzi M, Peterson LM, Linden HM, Novakova A, Mankoff DA, Kinahan PE.

Phys Med Biol. 2017 May 7;62(9):3639-3655. doi: 10.1088/1361-6560/aa6023. Epub 2017 Feb 13.

22.

A Multilab Preregistered Replication of the Ego-Depletion Effect.

Hagger MS, Chatzisarantis NLD, Alberts H, Anggono CO, Batailler C, Birt AR, Brand R, Brandt MJ, Brewer G, Bruyneel S, Calvillo DP, Campbell WK, Cannon PR, Carlucci M, Carruth NP, Cheung T, Crowell A, De Ridder DTD, Dewitte S, Elson M, Evans JR, Fay BA, Fennis BM, Finley A, Francis Z, Heise E, Hoemann H, Inzlicht M, Koole SL, Koppel L, Kroese F, Lange F, Lau K, Lynch BP, Martijn C, Merckelbach H, Mills NV, Michirev A, Miyake A, Mosser AE, Muise M, Muller D, Muzi M, Nalis D, Nurwanti R, Otgaar H, Philipp MC, Primoceri P, Rentzsch K, Ringos L, Schlinkert C, Schmeichel BJ, Schoch SF, Schrama M, Schütz A, Stamos A, Tinghög G, Ullrich J, vanDellen M, Wimbarti S, Wolff W, Yusainy C, Zerhouni O, Zwienenberg M.

Perspect Psychol Sci. 2016 Jul;11(4):546-73. doi: 10.1177/1745691616652873.

PMID:
27474142
23.

The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge.

Huang W, Chen Y, Fedorov A, Li X, Jajamovich GH, Malyarenko DI, Aryal MP, LaViolette PS, Oborski MJ, O'Sullivan F, Abramson RG, Jafari-Khouzani K, Afzal A, Tudorica A, Moloney B, Gupta SN, Besa C, Kalpathy-Cramer J, Mountz JM, Laymon CM, Muzi M, Schmainda K, Cao Y, Chenevert TL, Taouli B, Yankeelov TE, Fennessy F, Li X.

Tomography. 2016 Mar;2(1):56-66.

24.

ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI.

Gerstner ER, Zhang Z, Fink JR, Muzi M, Hanna L, Greco E, Prah M, Schmainda KM, Mintz A, Kostakoglu L, Eikman EA, Ellingson BM, Ratai EM, Sorensen AG, Barboriak DP, Mankoff DA; ACRIN 6684 Trial Group.

Clin Cancer Res. 2016 Oct 15;22(20):5079-5086. Epub 2016 May 16.

25.

Imaging Hypoxia with ¹⁸F-Fluoromisonidazole: Challenges in Moving to a More Complicated Analysis.

Muzi M, Krohn KA.

J Nucl Med. 2016 Apr;57(4):497-8. doi: 10.2967/jnumed.115.171694. Epub 2016 Feb 18. No abstract available.

26.

Effect of 18F-FDG uptake time on lesion detectability in PET imaging of early stage breast cancer.

Wangerin KA, Muzi M, Peterson LM, Linden HM, Novakova A, O'Sullivan F, Kurland BF, Mankoff DA, Kinahan PE.

Tomography. 2015 Sep;1(1):53-60. Erratum in: Tomography. ;2(3):238.

27.

E-cigarettes as smoking cessation aids: a survey among practitioners in Italy.

Lazuras L, Muzi M, Grano C, Lucidi F.

Int J Public Health. 2016 Mar;61(2):243-8. doi: 10.1007/s00038-015-0772-x. Epub 2015 Dec 21.

28.

Trial & Guidelines.

Roumen R, Boelens O, Van Assen T, Scheltinga M, Wijerathne S, Agarwal N, Ramzi A, Liem D, Lomanto D, Simon T, Buechler MW, Koeckerling F, Siawash M, de Jager-Kieviet JW, Roumen RM, Scheltinga MR, Lincourt A, Augenstein V, Kercher K, Heniford B, Andresen K, Burcharth J, Hupfeld L, Fonnes S, Rothman JP, Winther D, Deigaard SL, Sørensen FS, Bjerg J, Therkildsen R, Errebo M, Hauge D, Rosenberg J, Fischer J, Fox J, Basta M, Kovach S, East B, Krejci T, Hoch J, Jorgensen LN, Kullman E, Tollens T, Nienhuijs S, Doerhoff C, Muzi MG, Hopson S, Velanovich V, Muysoms F, Leblanc K, Schwartz M, Berrevoet F, Holihan J, Nguyen DH, Flores-Gonzalez JR, Alawadi ZM, Nguyen MT, Kao LS, Liang MK, Hassan S, Raslan C, Henley N, Van Veenendaal N, Poelman MM, Van den Heuvel B, Schreurs H, Dwars B, Bonjer HJ, Kaufmann R, Halm JA, Nieuwenhuizen J, Klitsie P, Eker HH, van Geldere D, Simons MP, Van't Riet M, Jeekel J, Lange JF, Pathania B.

Hernia. 2015 Apr;19 Suppl 1:S43-9. doi: 10.1007/BF03355325. No abstract available.

PMID:
26518859
29.

Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size.

Kurland BF, Muzi M, Peterson LM, Doot RK, Wangerin KA, Mankoff DA, Linden HM, Kinahan PE.

J Nucl Med. 2016 Feb;57(2):226-30. doi: 10.2967/jnumed.115.162289. Epub 2015 Oct 22.

30.

A Phase II Study of 3'-Deoxy-3'-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688.

Kostakoglu L, Duan F, Idowu MO, Jolles PR, Bear HD, Muzi M, Cormack J, Muzi JP, Pryma DA, Specht JM, Hovanessian-Larsen L, Miliziano J, Mallett S, Shields AF, Mankoff DA; ACRIN 668 Investigative Team.

J Nucl Med. 2015 Nov;56(11):1681-9. doi: 10.2967/jnumed.115.160663. Epub 2015 Sep 10.

31.

Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging.

Fink JR, Muzi M, Peck M, Krohn KA.

J Nucl Med. 2015 Oct;56(10):1554-61. doi: 10.2967/jnumed.113.131516. Epub 2015 Aug 20. Review.

32.

18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions.

Muzi M, Peterson LM, O'Sullivan JN, Fink JR, Rajendran JG, McLaughlin LJ, Muzi JP, Mankoff DA, Krohn KA.

J Nucl Med. 2015 Aug;56(8):1223-8. doi: 10.2967/jnumed.115.158717. Epub 2015 Jun 25.

33.

Applications of PET imaging with the proliferation marker [18F]-FLT.

Peck M, Pollack HA, Friesen A, Muzi M, Shoner SC, Shankland EG, Fink JR, Armstrong JO, Link JM, Krohn KA.

Q J Nucl Med Mol Imaging. 2015 Mar;59(1):95-104. Epub 2015 Mar 4. Review.

34.

Castration-resistant prostate cancer bone metastasis response measured by 18F-fluoride PET after treatment with dasatinib and correlation with progression-free survival: results from American College of Radiology Imaging Network 6687.

Yu EY, Duan F, Muzi M, Deng X, Chin BB, Alumkal JJ, Taplin ME, Taub JM, Herman B, Higano CS, Doot RK, Hartfeil D, Febbo PG, Mankoff DA.

J Nucl Med. 2015 Mar;56(3):354-60. doi: 10.2967/jnumed.114.146936. Epub 2015 Jan 29.

35.

In silico validation procedure for cell volume fraction estimation through dielectric spectroscopy.

Frezza F, Mangini F, Muzi M, Stoja E.

J Biol Phys. 2015 Jun;41(3):223-34. doi: 10.1007/s10867-014-9374-8. Epub 2015 Jan 10.

36.

VOXEL-LEVEL MAPPING OF TRACER KINETICS IN PET STUDIES: A STATISTICAL APPROACH EMPHASIZING TISSUE LIFE TABLES.

O'Sullivan F, Muzi M, Mankoff DA, Eary JF, Spence AM, Krohn KA.

Ann Appl Stat. 2014 Jun 1;8(2):1065-1094.

37.

Long-term results of pilonidal sinus disease with modified primary closure: new technique on 450 patients.

Muzi MG, Maglio R, Milito G, Nigro C, Ciangola I, Bernagozzi B, Masoni L.

Am Surg. 2014 May;80(5):484-8.

PMID:
24887728
38.

Variations of dynamic contrast-enhanced magnetic resonance imaging in evaluation of breast cancer therapy response: a multicenter data analysis challenge.

Huang W, Li X, Chen Y, Li X, Chang MC, Oborski MJ, Malyarenko DI, Muzi M, Jajamovich GH, Fedorov A, Tudorica A, Gupta SN, Laymon CM, Marro KI, Dyvorne HA, Miller JV, Barbodiak DP, Chenevert TL, Yankeelov TE, Mountz JM, Kinahan PE, Kikinis R, Taouli B, Fennessy F, Kalpathy-Cramer J.

Transl Oncol. 2014 Feb 1;7(1):153-66. eCollection 2014 Feb.

39.

Errors in Quantitative Image Analysis due to Platform-Dependent Image Scaling.

Chenevert TL, Malyarenko DI, Newitt D, Li X, Jayatilake M, Tudorica A, Fedorov A, Kikinis R, Liu TT, Muzi M, Oborski MJ, Laymon CM, Li X, Thomas Y, Jayashree KC, Mountz JM, Kinahan PE, Rubin DL, Fennessy F, Huang W, Hylton N, Ross BD.

Transl Oncol. 2014 Feb 1;7(1):65-71. eCollection 2014 Feb.

40.
41.
42.

Efficacy and tolerability of fitostimoline (vaginal cream, ovules, and vaginal washing) and of benzydamine hydrochloride (tantum rosa vaginal cream and vaginal washing) in the topical treatment of symptoms of bacterial vaginosis.

Boselli F, Petrella E, Campedelli A, Muzi M, Rullo V, Ascione L, Papa R, Saponati G.

ISRN Obstet Gynecol. 2012;2012:183403. doi: 10.5402/2012/183403. Epub 2012 Oct 30.

43.

Quantitative assessment of dynamic PET imaging data in cancer imaging.

Muzi M, O'Sullivan F, Mankoff DA, Doot RK, Pierce LA, Kurland BF, Linden HM, Kinahan PE.

Magn Reson Imaging. 2012 Nov;30(9):1203-15. doi: 10.1016/j.mri.2012.05.008. Epub 2012 Jul 21. Review.

44.

Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO-PET images.

Gu S, Chakraborty G, Champley K, Alessio AM, Claridge J, Rockne R, Muzi M, Krohn KA, Spence AM, Alvord EC Jr, Anderson AR, Kinahan PE, Swanson KR.

Math Med Biol. 2012 Mar;29(1):31-48. doi: 10.1093/imammb/dqr002. Epub 2011 May 11.

45.

Multiagent PET for risk characterization in sarcoma.

Eary JF, Link JM, Muzi M, Conrad EU, Mankoff DA, White JK, Krohn KA.

J Nucl Med. 2011 Apr;52(4):541-6. doi: 10.2967/jnumed.110.083717. Epub 2011 Mar 18.

46.

PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptake.

Dunnwald LK, Doot RK, Specht JM, Gralow JR, Ellis GK, Livingston RB, Linden HM, Gadi VK, Kurland BF, Schubert EK, Muzi M, Mankoff DA.

Clin Cancer Res. 2011 Apr 15;17(8):2400-9. doi: 10.1158/1078-0432.CCR-10-2649. Epub 2011 Mar 1.

47.

C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy.

Yu EY, Muzi M, Hackenbracht JA, Rezvani BB, Link JM, Montgomery RB, Higano CS, Eary JF, Mankoff DA.

Clin Nucl Med. 2011 Mar;36(3):192-8. doi: 10.1097/RLU.0b013e318208f140.

48.

Acacia honey and chrysin reduce proliferation of melanoma cells through alterations in cell cycle progression.

Pichichero E, Cicconi R, Mattei M, Muzi MG, Canini A.

Int J Oncol. 2010 Oct;37(4):973-81.

PMID:
20811719
49.

Randomized comparison of Limberg flap versus modified primary closure for the treatment of pilonidal disease.

Muzi MG, Milito G, Cadeddu F, Nigro C, Andreoli F, Amabile D, Farinon AM.

Am J Surg. 2010 Jul;200(1):9-14. doi: 10.1016/j.amjsurg.2009.05.036.

PMID:
20637332
50.

Regional P-glycoprotein activity and inhibition at the human blood-brain barrier as imaged by positron emission tomography.

Eyal S, Ke B, Muzi M, Link JM, Mankoff DA, Collier AC, Unadkat JD.

Clin Pharmacol Ther. 2010 May;87(5):579-85. doi: 10.1038/clpt.2010.11. Epub 2010 Mar 24.

Supplemental Content

Support Center